CEFTAZIDIME-VIT 2 G.

Maa: Israel

Kieli: englanti

Lähde: Ministry of Health

Aktiivinen ainesosa:

CEFTAZIDIME AS PENTAHYDRATE

Saatavilla:

VITAMED PHARMACEUTICAL INDUSTRIES LTD

ATC-koodi:

J01DD02

Lääkemuoto:

POWDER FOR SOLUTION FOR INJ/INF

Koostumus:

CEFTAZIDIME AS PENTAHYDRATE 2 G/VIAL

Antoreitti:

I.V

Prescription tyyppi:

Required

Valmistaja:

ACS DOBFAR S.P.A, ITALY

Terapeuttinen alue:

CEFTAZIDIME

Käyttöaiheet:

Ceftazidime-VIT 2 G is indicated for the treatment of the infections listed below in adults and children including neonates (from birth).•Nosocomial pneumonia•Broncho-pulmonary infections in cystic fibrosis•Bacterial meningitis•Chronic suppurative otitis media•Malignant otitis externa•Complicated urinary tract infections•Complicated skin and soft tissue infections•Complicated intra-abdominal infections•Bone and joint infections•Peritonitis associated with dialysis in patient on CAPD.Treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. Ceftazidime VIT 2 G may be used in the management of neutropenic patients with fever that is suspected to be due to abacterial infection. Ceftazidime VIT 2 G may be used in the peri-operative prophylaxis of urinary tract infections for patients undergoing trans-urethral resection of the prostate (TURP). The selection of ceftazidime should take into account its antibacterial spectrum, which is mainly restricted to aerobic Gram negative bacteria. Ceftazidime VIT 2 G should be co-administered with other antibacterial agents whenever the possible range of causive bacteria would not fall within its spectrum of activity. Consideration should be given to official guidelines on the appropriate use of antibacterial agents.

Valtuutus päivämäärä:

2023-07-12